General Electric Company’s (NYSE:GE) GE Healthcare reported Wednesday the results of three health economic models which estimate the potential cost offsets to the healthcare system of biomarker testing in patients suffering from early breast cancer, metastatic breast cancer and renal cell carcinoma, to guide therapy selection. The firm supplies transformational medical technologies and services which are defining a new age of patient care that said in two of the three studies, data indicated that use of angiogenesis-specific biomarker imaging tests could decrease costs by early determination of response to therapy and early identification of rapid disease progression.Ger Brophy, Head of New Product Development, GE Healthcare Medical Diagnostics said that “We recognize that early economic evaluations of potential biomarker-guided treatment pathways can provide useful preliminary information to developers, clinicians and payers.”
Alcoa (NYSE:AA) on Wednesday congratulated Tesla Motors on its Tesla Model S electric vehicle, which is an all-aluminum premium sedan, and has been chosen Automobile Magazine‘s 2013 Car of the Year. The body of Model S consists of a state-of-the-art, aluminum-intensive design which has won raves across the industry. It can accelerate from 0 to 60 in 5.6 seconds, with no tailpipe emissions.
Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.
Hewlett-Packard Company’s (NYSE:HPQ) long-standing relationship with the huge fast moving consumer goods dealer Procter & Gamble Co. was further reinforced with the most recent information tech service deal between the two firms. On Wednesday, H-P announced that it will extend its application service support in order to help P&G manage supply chain operations efficiently. Through the terms, H-P will offer its Applications Development Services and Applications Management Services, which solutions will support P&G’s mission critical business applications, and thus help it in inventory management, research and development, enterprise resource planning and business intelligence.
Merck & Co.(NYSE:MRK) is among health care-related firms whose shares were down following President Obama’s re-election that makes a repeal of the Affordable Care Act extremely unlikely. Among pharmaceutical firms, Merck was down 3 percent at mid-day; with Johnson & Johnson (NYSE: JNJ) down by 1 percent; and Pfizer (NYSE: PFE) 0.8 percent. In addition, insurance provider stocks also fell; UnitedHealth Group (NYSE: UNH) was down almost 4 percent in mid-day trading.